Aderbasib,
791828-58-5,
(6S,7S)-Methyl 7-(hydroxycarbamoyl)-6-(4-phenylpiperazine-1-carbonyl)-5-azaspiro[2.5]octane-5-carboxylate,
UNII-V9YL6NEJ3G,
INCB7839,
INCB 007839,
V9YL6NEJ3G,
C21H28N4O5,
methyl (6S,7S)-7-(hydroxycarbamoyl)-6-(4-phenylpiperazine-1-carbonyl)-5-azaspiro[2.5]octane-5-carboxylate,
Aderbasib [USAN:INN],
INCB-007839,
Aderbasib (USAN/INN),
SCHEMBL206421,
CHEMBL2103790,
CTK8C1920,
2391AC,
ANW-67454,
MFCD13195569,
ZINC34997457,
AKOS016006558,
API0013945,
SB17076,
NCGC00498399-01,
AJ-90572,
AN-16582,
AS-35272,
SC-69845,
TC-156199,
D09320,
828A585,
(6S,7S)-7-[(Hydroxyamino)carbonyl]-6-[(4-phenyl-1-piperazinyl)carbonyl]-5-azaspiro[2.5]octane-5-carboxylic Acid Methyl Ester,
(6S,7S)-Methyl 7-(hydroxycarbamoyl)-6-(4-phenylpiperazine-1-carbonyl)-5-azaspiro[2.5]octane-5-carbox,
5-Azaspiro(2.5)octane-5-carboxylic acid, 7-((hydroxyamino)carbonyl)-6-((4-phenyl-1-piperazinyl)carbonyl)-, methyl ester, (6S,7S)-,
methyl (5S,6S)-5-(hydroxycarbamoyl)-6-(4-phenylpiperazine-1-carbonyl)-7-azaspiro[2.5]octane-7-carboxylate,
Methyl (6S,7S)-7-((hydroxyamino)carbonyl)-6-((4-phenylpiperazin-1-yl)carbonyl)-5-azaspiro(2.5)octane-5-carboxylate,
Aderbasib [USAN],
D02CZF,
INCB-7839,
ADAM inhibitors (oral, cancer), Incyte,
Sheddase inhibitors (anticancer), Incyte,